DAIC

JUNE 12, 2024

It enrolled 162 subjects at 30 centers with three patient populations – non-thrombotic iliac vein lesion (NIVL), post-thrombotic syndrome (PTS) and acute deep vein thrombosis (aDVT). Ultimately, the new device promises to enable excellent clinical outcomes and drive significant quality of life improvements.”

Stents 105

Stents Stent Anatomy Ultrasound 105

Circulation: Cardiovascular Interventions

JANUARY 24, 2024

Principal safety outcomes were independently adjudicated International Society on Thrombosis and Haemostasis major bleeding at 72 hours post-treatment and mortality within 12 months of treatment. One patient experienced worsening of a preexisting subdural hematoma after USCDT and therapeutic anticoagulation, which ultimately required surgery.

Embolism 75

Embolism Thrombolysis Ultrasound Pulmonary 75

Frontiers in Cardiovascular Medicine

FEBRUARY 15, 2024

The scores of the Venous Thrombosis Knowledge, Participation in Thrombosis Prevention Willingness and Behavior Questionnaire, and Quality of Life Measurement Scale (QLQ-C30) were compared before the intervention and after three months.

Cancer 49

Cancer Thrombosis Quality of Life Nursing 49

Stroke Journal

JANUARY 30, 2025

Introduction:The majority of patients with cerebral venous thrombosis (CVT) achieve functional independence (modified Rankin Score [mRS] 0-2), although many continue to experience residual symptoms that negatively impact quality of life. Stroke, Volume 56, Issue Suppl_1 , Page AWP143-AWP143, February 1, 2025.

Thrombosis 40

Thrombosis Stroke Strokes Outcomes 40

DAIC

MARCH 8, 2024

Patients with heart failure often experience reduced mobility, quality of life and ability to work; the disease also represents a significant public health care burden. However, there are shortcomings associated with LVAD implantation: complications include infection, blood clotting (thrombosis), stroke and bleeding.

Blood Clot 98

Blood Clot Heart Failure Quality of Life Innovation 98

DAIC

FEBRUARY 18, 2025

Previous studies about heart valve disease have focused on procedural or device outcomes, and less on patient-centered and disease-related outcomes that are relevant to patients physical and mental well-being and quality of life.

Heart Valves 52

Heart Valves Quality of Life Cardiothoracic Outcomes 52

Circulation

NOVEMBER 11, 2024

However, it subjects patients to lifelong warfarin therapy after MHVR, with the attendant risk of bleeding and thrombosis. The percentage of time in the therapeutic range (TTR) was used as the primary outcome while bleeding, thrombosis, and other events were the secondary outcomes.Results:A total of 721 patients were enrolled.

Heart Valves 40

Heart Valves Embolism Thrombosis Quality of Life 40